FDA issues new clinical data collection guidance
This article was originally published in Clinica
Executive Summary
Medical device companies are being urged to follow the US FDA's new guidance on how to collect clinical data on ethnic and radical demographic groups. The FDA currently requires drug companies to include an analysis of data based on age, gender and race when conducting a clinical trial.